Search hospitals > Ohio > Cincinnati

The Christ Hospital

Claim this profile
Cincinnati, Ohio 45219
Global Leader in Coronary Artery Disease
Global Leader in Breast Cancer
Conducts research for Heart Failure
Conducts research for Cancer
Conducts research for Melanoma
270 reported clinical trials
27 medical researchers
Photo of The Christ Hospital in CincinnatiPhoto of The Christ Hospital in CincinnatiPhoto of The Christ Hospital in Cincinnati

Summary

The Christ Hospital is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Coronary Artery Disease, Breast Cancer, Heart Failure, Cancer, Melanoma and other specialties. The Christ Hospital is involved with conducting 270 clinical trials across 304 conditions. There are 27 research doctors associated with this hospital, such as Timothy R Smith, Alexander Starodub, MD, Santiago Garcia, MD, and Gina G. Chung.

Area of expertise

1Coronary Artery Disease
Global Leader
The Christ Hospital has run 25 trials for Coronary Artery Disease.
2Breast Cancer
Global Leader
The Christ Hospital has run 24 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 positive
HER2 negative

Top PIs

Clinical Trials running at The Christ Hospital

Breast Cancer
Heart Failure
Mitral Valve Regurgitation
Non-Small Cell Lung Cancer
Solid Tumors
Aortic Valve Stenosis
Tumors
Colorectal Cancer
Hepatitis C
Ovarian Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Chemotherapy Reduction After Surgery

for Breast Cancer

This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at The Christ Hospital?
The Christ Hospital is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Coronary Artery Disease, Breast Cancer, Heart Failure, Cancer, Melanoma and other specialties. The Christ Hospital is involved with conducting 270 clinical trials across 304 conditions. There are 27 research doctors associated with this hospital, such as Timothy R Smith, Alexander Starodub, MD, Santiago Garcia, MD, and Gina G. Chung.